Showing results (101-110 of 141) with videos related to
Sort By:
Pageof 15
Future Oncology (London, England)|July 30, 2026
Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United StatesJennifer R Brown, Talha Munir, Andrew H Lipsky, et al.Pharmacology|December 31, 1997
Inhibition of growth factor mitogenicity and growth of tumor cell xenografts by a sulfonated distamycin A derivativeP W Finch, L K Yee, M Y Chu, et al.Journal of Human Genetics|December 14, 2004
Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each geneInna Belfer, Beata Buzas, Heather Hipp, et al.European Journal of Human Genetics : EJHG|November 4, 2004
Haplotype structure of the beta adrenergic receptor genes in US Caucasians and African AmericansInna Belfer, Beata Buzas, Catherine Evans, et al.Pharmacology|July 8, 1998
Predictive sensitivity of human cancer cells in vivo using semipermeable polysulfone fibersM Y Chu, M H Lipsky, L K Yee, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 17, 2005
BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effectsXueying Jiang, Ke Xu, Joelle Hoberman, et al.Aging|April 26, 2017
Functional human GRIN2B promoter polymorphism and variation of mental processing speed in older adultsYang Jiang, Ming Kuan Lin, Gregory A Jicha, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2009
Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for strokeNicolas Blondeau, Carine Nguemeni, David N Debruyne, et al.Hematological Oncology|June 4, 2026
Bendamustine/Rituximab Induction Followed by Venetoclax/Rituximab Consolidation in Frontline Treatment of Chronic Lymphocytic Leukemia: A Phase 2 Multi-Center StudyAndrew H Lipsky, Brian T Hill, Allison Winter, et al.The Journal of Experimental Medicine|July 24, 2013
CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell responseMarc Martínez-Llordella, Jonathan H Esensten, Samantha L Bailey-Bucktrout, et al.Pageof 15